+ All Categories
Home > Documents > PRESENTATION OVERVIEW

PRESENTATION OVERVIEW

Date post: 24-Feb-2016
Category:
Upload: zaria
View: 30 times
Download: 0 times
Share this document with a friend
Description:
EFFECTIVE Treatment for substance use disorders CARL M. DAWSON , M.S. , MAC , LPC THE FOREST INSTITUTE OF PROFESSIONAL PSYCHOLOGY Springfield , missouri NATIONAL DRUG COURT INSTITUTE ( NDCI ) WASHINGTON , DC. PRESENTATION OVERVIEW. ADOLESCENCE AND ADULT - PowerPoint PPT Presentation
Popular Tags:
43
EFFECTIVE TREATMENT FOR SUBSTANCE USE DISORDERS CARL M. DAWSON , M.S. , MAC , LPC THE FOREST INSTITUTE OF PROFESSIONAL PSYCHOLOGY SPRINGFIELD , MISSOURI NATIONAL DRUG COURT INSTITUTE ( NDCI ) WASHINGTON , DC
Transcript
Page 1: PRESENTATION  OVERVIEW

EFFECTIVE TREATMENT FOR SUBSTANCE USE DISORDERS

CARL M. DAWSON , M.S. , MAC , LPC

THE FOREST INSTITUTE OF PROFESSIONAL PSYCHOLOGY SPRINGFIELD , MISSOURI

NATIONAL DRUG COURT INSTITUTE ( NDCI )WASHINGTON , DC

Page 2: PRESENTATION  OVERVIEW

PRESENTATION OVERVIEW ADOLESCENCE AND ADULT TREATMENT DIFFERENCES .

GENDER DIFFERENCES AND SUBSTANCE ABUSE TREATMENT . CLINICAL POINTS OF REFERENCE “ TREATMENT “ ISSUES .

THIRTEEN ( 13 ) NECESSARY COMPONENTS OF AN EFFECTIVE SUBSTANCE ABUSE TREATMENT PROGRAM .

THE FUTURE USE OF MEDICATION ( INTERVENTION ) POSSIBILITIES IN TREATMENT .

Page 3: PRESENTATION  OVERVIEW

KEEPING PERSPECTIVE

Remember : Our initial goal during the early months of recovery is not to focus on the idea of long term sobriety, but to keep the person from relapsing . Relapse is and will always be our enemy . During early recovery, focus on teaching the individual(s) how not to relapse and what it will take for them to stay drug free long enough until they feel confident about not using, and experienced enough time to reestablish a new life without the use mood altering substances .

Page 4: PRESENTATION  OVERVIEW

POINTS OF REFERENCE

EVERY INDIVIDUAL THAT ENTERS INTO THE PROCESS OF RECOVERY IS CURSED WITH KNOWING THAT THEY POSSESS ONE MORE RELAPSE . . . WHAT THEY DON’T KNOW IS HOW MANY MORE OPPORTUNITES , IF EVER , THEY WILL HAVE TO RECOVER !

Page 5: PRESENTATION  OVERVIEW

Maslow’s Needs

Individuals in recovery may need to

re-experience and redefine each stage of emotional development before their healing is complete .

Page 6: PRESENTATION  OVERVIEW

POINTS OF REFERENCE

NINETY ( 90 % ) OF SUCCESSFUL RECOVERY OCCURS AFTER THE INDIVIDUAL COMPLETES FORMAL TREATMENT .

NETWORK THERAPIES : INVOLVING AFTERCARE COUNSELING , SELF - HELP GROUPS , SPONSERSHIP , AND CONTINUED INVOLVEMENT IN RECOVERY ORIENTED ACTIVITIES FOR A PERIOD OF THREE ( 3 ) TO FIVE ( 5 ) YEARS HAVE BEEN FOUND TO BE MOST EFFECTIVE WITH REGARDS TO ESTABLISHING A LONG TERM RECOVERY AND RELAPSE PREVENTION PROGRAM .

MOST RESEARCH ESTIMATES THAT MORE THAN NINETY ( 90% ) RELAPSE ONE TIME BEFORE GAINING SOLID RECOVERY .

Page 7: PRESENTATION  OVERVIEW

GENDER DIFFERENCES AND SUBSTANCE ABUSE TREATMENT

WOMEN ( GIRLS ) IN TREATMENT , BLAME “ STRESS “ AS THEIR MOST COMMON REASON FOR USING DRUGS .

MEN ( BOYS ) IN TREATMENT ROUTINELY STATE THAT “ PEER PRESSURE “ WAS THEIR INITIAL REASON FOR THEIR USE OF DRUGS .

Page 8: PRESENTATION  OVERVIEW

GENDER DIFFERENCES

WOMEN ( GIRLS ) IN TREATMENT ARE MORE FREQUENTLY IDENTIFIED AS HAVING HAD A

PRE – EXISTING “ MOOD “ DISORDER PRIOR TO THEIR USE OF DRUGS .

MEN ( BOYS ) IN TREATMENT , ARE FREQUENTLY FOUND TO HAVE AQUIRED A “ MOOD “ DISORDER AFTER THEIR INITIAL

INTRODUCTION AND USE OF DRUGS .

Page 9: PRESENTATION  OVERVIEW

GENDER DIFFERENCES

WOMEN ( GIRLS ) IN GENERAL ARE TWICE ( 2 X’s ) AS LIKELY TO STRUGGLE WITH DEPRESSION AND ANXIETY RELATED MOOD DISORDERS THEN MEN .

AS A CONSEQUENCE . . . THEY ARE ALSO MORE LIKELY TO BE ATTRACTED TO ILLICIT DRUGS THAT POSSESS : “ ANTI – DEPRESSANT “ PROPERITIES , LIKE AMPHETAMINES , METHAMPHETAMINE AND COCAINE AND . . . PERSCRIPTION “ ANTI – ANXIETY “ MEDICATIONS LIKE XANAX OR SEDATIVE – HYPNOTIC SUBSTANCES “ SLEEP – AIDS “ .

Page 10: PRESENTATION  OVERVIEW

GENDER DIFFERENCES

WOMEN SUBSTANCE ABUSERS REPORT STRUGGLING MORE WITH “ SHAME ”

OR . . .

“ WHAT’S WRONG WITH ME ! ”

MEN SUBSTANCE ABUSERS REPORT STRUGGLING MORE WITH FEELINGS OF “ GUILT ” OR . . . “ I KNOW I DID SOMETHING WRONG ! ”

Page 11: PRESENTATION  OVERVIEW

GENDER DIFFERENCES

WOMEN ( GIRLS ) IN TREATMENT , ARE FOUND TO RESPOND MORE EFFECTIVELY TO A “ LESS – CONFRONTATIONAL “ THERAPEUTIC COMMUNITY , . . . THAT EMPHASIZES AND REWARDS . . . 1. POSITIVE SELF - GROWTH , 2. ESTEEM BUILDING AND DEVELOPMENT ,3. PERSONAL EMPOWERMENT .

Page 12: PRESENTATION  OVERVIEW

GENDER DIFFERENCES

MEN ( BOYS ) IN TREATMENT , ARE FOUND TO RESPOND MORE POSITIVELY TO TRADITIONAL TREATMENT CONCEPTS INVOLVING A . . .

1. MORE DIRECT “ CONFRONTATIONAL “ THERAPEUTIC APPROACH . 2. SELF – HELP GROUPS, ( A. A. / N. A. ) . . . 3. ISSUES SURROUNDING “ POWERLESSNESS “ , “ LIFE UNMANAGIBILITY “ .

Page 13: PRESENTATION  OVERVIEW

GENDER DIFFERENCES

RESEARCH ON WOMEN ( GIRLS ) AND STIMULANT DRUG USAGE , FINDS THE FOLLOWING :

WOMEN ( GIRLS ) ARE LIKELY TO DEVELOP A DEPENDENCY ON METHAMPHETAMINE AND COCAINE SOONER THEN MEN ,

THEY ARE PRONE TO USE STIMULANT DRUGS MORE IMPULSIVELY THAN MEN ( BOYS ) AND ,

EXPERENCE A HIGHER RATE OF DRUG RELAPSE THAN MEN ( BOYS ) .

Page 14: PRESENTATION  OVERVIEW

DAWSON’S HYPOTHESIS OF CHANGE

A PERSON WILL RARELY SEEK TO CHANGE THEIR BEHAVIOR(S) UNTIL . . . THEY EXPERIENCE THAT MOMENT OF REALITY . . . WHEN THEY REALIZE , THEY . . . ARE THE ONLY ONE TRULY RESPONSIBLE FOR THEIR PRESENT SUFFERING ! ! !

Page 15: PRESENTATION  OVERVIEW

CLINICAL POINTS OF REFERENCE “ TREATMENT “ ISSUES

“ COMPLETE ABSTINENCE FROM THE USE OF ALL MOOD ALTERING SUBSTANCES , INCLUDING THE INDIVIDUALS “ LEAST “ DRUG OF CHOICE , SHOULD BE THE FUNDAMENTAL PHILOSOPHY AND GOAL OF EVERY EFFECTIVE TREATMENT PROGRAM .

Page 16: PRESENTATION  OVERVIEW

REMEMBER : CURRENT THERAPEUTIC APPROACHES ONLY IMPACT APPROXIMATELY 1 BILLION OF THE 100 BILLION NEURONS IN THE HUMAN BRAIN .

Page 17: PRESENTATION  OVERVIEW

“ TREATMENT “ ISSUES

GROUP DIRECTED TREATMENT HAS BEEN FOUND TO BE MORE EFFECTIVE WHEN TREATING ADDICTION DISORDERS THAN INDIVIDUALLY DIRECTED TREATMENT .

“ CULTURAL “ SPECIFIC TREATMENT HAS BEEN FOUND TO BE MORE EFFECTIVE THAN “ GENERIC “ ORIENTED

TREATMENT .

FAMILY THERAPY AND FAMILY INVOLVEMENT IS THE “ MISSING LINK “ AND KEY FACTOR IN ALL EFFECTIVE SUBSTANCE USE TREATMENT .

Page 18: PRESENTATION  OVERVIEW

“ TREATMENT “ ISSUES

“ RESIDENTIAL “ DRUG TREATMENT HAS BEEN FOUND TO BE MORE EFFECTIVE THAN “ OUTPATIENT “ DRUG TREATMENT WHEN ADDRESSING ADOLESCENT ADDICTION ISSUES .

“ PERSONALLY “ AND “ PROFESSIONALLY “ , I WILL NOT REFER TO A TREATMENT PROGRAM THAT DOES NOT EMPHASIZE THE PRIMARY PRINCIPLES AND PHILOSOPHIES OF THE ALCOHOLICS ANONMYOUS ( A .A .) PROGRAM .

Page 19: PRESENTATION  OVERVIEW

“ TREATMENT “ ISSUES

WHAT AGE DID THE INDIVIDUAL FIRST BEGAN USING DRUGS ?

THAT IS THE EMOTIONAL AGE OF THE INDIVIDUAL . . . AND EMOTIONALLY THAT IS WHERE DRUG TREATMENT SHOULD BEGAN .

REMEMBER : FOR DRUG TREATMENT TO BE EFFECTIVE , YOU MUST BEGAN WHERE THE INDIVIDUAL IS . . . NOT WHERE YOU WANT THEM TO BE !!!

Page 20: PRESENTATION  OVERVIEW

“ TREATMENT “ ISSUES

FOR ADDICTION TREATMENT TO BE EFFECTIVE . . . THE INDIVIDUAL MUST BE WILLING OR FORCED TO CHANGE :

PLAY - GROUNDS , ( Bars , Clubs, Parties )

PLAY - MATES , ( Using friends ) PLAY - THINGS , ( Drug paraphernalia )

Page 21: PRESENTATION  OVERVIEW

THIRTEEN ( 13 ) NECESSARY COMPONENTS OF AN EFFECTIVE DRUG AND ALCOHOL TREATMENT PROGRAM

Page 22: PRESENTATION  OVERVIEW

( 1 ) NO SINGLE TREATMENT IS APPROPRIATE FOR ALL INDIVIDUALS

PROPER IDENTIFICATION AND PLACEMENT IS CRUCIAL IN DETERMINING CLIENT - TREATMENT COMPLIANCE AND SUCCESS .

RESEARCH CONDUCTED BY CSAT AT UCLA CONCLUDED : THE MATRIX MODEL APPLIED TO A DRUG COURT PHILOSOPHY WAS MORE EFFECTIVE THAN TREATMENT AS USUAL .

Page 23: PRESENTATION  OVERVIEW

( 2 ) TREATMENT NEEDS TO BE READILY AVAILABLE

STRIKE WHILE THE IRON IS HOT !

POTENTIAL TREATMENT APPLICANTS CAN BE LOST IF TREATMENT IS NOT IMMEDIATELY AVAILABLE OR IS NOT READILY ACCESSIBLE .

Page 24: PRESENTATION  OVERVIEW

( 3 ) EFFECTIVE TREATMENT ATTENDS TO THE MULTIPLE NEEDS OF THE INDIVIDUAL . . . NOT JUST THEIR DRUG USE

IN ORDER FOR TREATMENT TO BE EFFECTIVE A TREATMENT PROGRAM MUST BE ABLE TO ADDRESS THE INDIVIDUALS DRUG USE . . . AND OTHER MEDICAL , PSYCHOLOGICAL , VOCATIONAL , SOCIAL , AND LEGAL PROBLEMS .

Page 25: PRESENTATION  OVERVIEW

( 4 ) A CLIENTS TREATMENT PLAN NEEDS TO BE PERIODICALLY REVIEWED TO ENSURE THAT THE PLAN IS MEETING THE CLIENTS CHANGING NEEDS

A CLIENT THAT REQUIRES MULTIPLE COMBINATIONS OF ASSISTANCE WILL REQUIRE MORE TIME AND ATTENTION TO ENSURE SUCCESSFUL COMPLIANCE AND PARTICIPATION IN TREATMENT .

Page 26: PRESENTATION  OVERVIEW

( 5 ) THE LENGTH OF TIME IN TREATMENT IS CRITICAL FOR OVERALL TREATMENT EFFECTIVENES

MOST RESEARCH INDICATES THAT A MINIMUM OF THREE ( 3 ) MONTHS OF CONTINUOUS TREATMENT IS NECESSARY FOR A SUCCESSFUL TREATMENT OUTCOME .

THE RESEARCH ALSO INDICATES THAT THE LONGER A PERSON REMAINS IN CONTINUOUS TREATMENT ( from 3 T0 14 mo. ) THE RELAPSE POTENTIAL RATE DROPS SIGNIFICIANTLY .

Page 27: PRESENTATION  OVERVIEW

( 6 ) COGNATIVE – BEHAVIORAL THERAPIES ARE MOST EFFECTIVE IN TREATING ADDICTION DISORDERS

( MULTI – DISCIPLINARY TREATMENT ) INVOLVING GROUP THERAPIES , INFORMATIONAL LECTURES , DIDACTIC DISCUSSIONS , PEER INTERACTION ( A.A. OR N.A ) , PROBLEM SOLVING AND SKILL’S BUILDING , MARTIAL COUNSELING AND FAMILY INVOLVEMENT IS MOST EFFECTIVE IN SUBSTANCE ABUSE TREATMENT .

Page 28: PRESENTATION  OVERVIEW

( 7 ) EFFECTIVE TREATMENT PROGRAMS SHOULD BE CAUTIOUS BUT WILLING TO CONSIDER THE USE OF APPROPRIATE MEDICATIONS

PSYCHO - PHARMACOLOGICAL INTERVENTION IS PROVING TO BE AN IMPORTANT AND SOMETIMES NECESSARY ADDITION TO TRADITIONAL SUBSTANCE ABUSE TREATMENT .

( PLEASE . . .DON’T KILL THE MESSENGER ! )

Page 29: PRESENTATION  OVERVIEW

( 8 ) CO – EXISTING ( SUBSTANCE ABUSE AND PSYCHIATRIC DISORDERS ) NEED TO BE ADDRESSED IN AN EFFECTIVE TREATMENT PROGRAM

SUICIDE : FOUR ( 4 ) OUT OF FIVE ( 5 ) . MOOD DISORDERS : Bi – Polar : ( 20 % to 60 % ) . Depression : ( 98 % ) . ANXIETY DISORDERS : ( 23 %) . STRESS -TRAUMA DISORDERS : ( 60% TO 80%) . PERSONALITY DISORDERS : ( 40% ) . PSYCHOTIC DISORDERS : ( 14% TO 47 % ) .

Page 30: PRESENTATION  OVERVIEW

( 9 ) MEDICAL DETOXIFICATION AND INTERVENTION IS ONLY THE “ FIRST “ STAGE OF TREATMENT

MEDICAL INTERVENTION , IDENTIFICATION , DIAGNOSIS AND DETOXIFICATION ARE CRITICAL FIRST STEPS IN EFFECTIVE SUBSTANCE ABUSE TREATMENT .

Page 31: PRESENTATION  OVERVIEW

( 10 ) TREATMENT DOES NOT HAVE TO BE VOLUNTARY TO BE EFFECTIVE

REMEMBER : DAWSON’S HYPOTHESIS OF CHANGE ! ! !

SANCTIONS AND BEING FORCED TO BE RESPONSIBLE , RELIABLE , DEPENDABLE , AND CONSISTANT . . . HAS BEEN FOUND TO BE A STRONG MOTIVATION TO ATTEND , PARTICIPATE , AND COMPLETE TREATMENT .

Page 32: PRESENTATION  OVERVIEW

( 11 ) POSSIBLE DRUG USE DURING TREATMENT MUST BE MONITORED CONTINUOUSLY

DRUG MONITORING HOLDS THE CLIENT RESPONSBILE TO THEIR COMMITMENTS .

DRUG MONITORING PERMITS THE TREATMENT TEAM TO ADJUSTED AN INDIVIDUALS TREATMENT PLAN ACCORDING TO THE NEEDS OF THE INDIVIDUAL .

Page 33: PRESENTATION  OVERVIEW

( 12 ) EFFECTIVE TREATMENT PROGRAMS SHOULD HAVE AVAILABLE . . . OR ACCESS TO . . . ASSESSMENT AND COUNSELING SERVICES FOR HIV - AIDS , HEPATITIS “ B ” AND “ C “, TUBERCULOSIS AND OTHER INFECTIOUS DISEASES THAT PLACE THEM OR OTHERS AT RISK OF INFECTION .

Page 34: PRESENTATION  OVERVIEW

( 13 ) TREATMENT AND RECOVERY IS LONG TERM PROCESS . . . PRONE TO EPISODES OF RELAPSE AND MULTIPLE TREATMENT ATTEMPTS

REMEMBER : TREATMENT AND RECOVERY FROM ALCOHOL AND DRUGS IS A PROCESS . . . NOT AN EVENT !

Page 35: PRESENTATION  OVERVIEW

USING MEDICATIONS IN TREATMENT

CURRENTLY THERE ARE EFFECTIVE MEDICATIONS THAT ASSIST HEALTH CARE PROFESSIONALS IN TREATING PSYCHIATRIC DISORDERS , SLEEP DISORDERS ,

NEUROLOGICAL DISORDERS , AND PHYSICAL – MEDICAL DISEASES . WE ARE IN PART AN “ CHEMICAL “ ORGANISM .

CONSIDER THAT IN THE FUTURE , TREATMENT OF CHEMICAL DEPENDENCY DISORDERS WILL AND SHOULD INCLUDE THE PROPER BALANCE OF THERAPEUTIC INTERVENTIONS THAT INCLUDE ,

CONVENTIONAL COUNSELING TECHNIQUES , EDUCATION , PREVENTION , SELF – HELP GROUPS ,

PSYCHOLOGY , MEDICINE , SPIRITUALITY AND CHEMISTRY .

Page 36: PRESENTATION  OVERVIEW

CURRENT AND FUTURE “ CRAVING “ MEDICATIONS

ALCOHOL : DISULFRAM “ANTABUSE “ . ACAMPROSATE “CAMPARAL ‘’ . NALTREXONE “ VIVITROL “ . GABAPENTIN “ NEURONTIN “ : IMPACT THE GABA SYSTEM . BACLOFEN : AN ANTI – ANXIETY AGENT THAT IMPACTS THE GABA SYSTEM . TOPIRAMATE “ TOPAMAX “ : IMPACTS THE GABA AND THE GLUTAMATE SYSTEM .

Page 37: PRESENTATION  OVERVIEW

COCAINE AND METHAMPHETAMINE ( S ) : ANTI–DEPRESSANTS “ SSRI’S “ , “SNRI’S “ .

MEDICATIONS TARGETING THE INSULAR CORTEX OF THE BRAIN .

A COCAINE VACCINE DEVELOPED DR. THOMAS KOSTEN , BAYLOR COLLEGE OF MEDICINE .

Page 38: PRESENTATION  OVERVIEW

THE INSULAR REGIONS THE BRAIN ALSO ASSOCIATED WITH “ CRAVINGS “

Page 39: PRESENTATION  OVERVIEW

MARIJUANA : RIMONABANT “ ACOMPLIA “ IMPACTS THE ENDOCANNABINOID SYSTEM .

TOBACCO : VARENICLINE “CHANTIX “ . ANTI – DEPRESSANTS

“ WELLBUTRIN “ . A NICOTINE VACCINE INVENTED BY NABI BIOPHARM , MARYLAND .

OPIATES : METHADONE , NALOXONE , NALTREXONE , BUPRENORPHINE .

Page 40: PRESENTATION  OVERVIEW

CONTACT INFORMATION :

CARL M. DAWSON , M.S. MAC , LPC

1320 E. KINGSLEY SUITE “ A “SPRINGFIELD, MO . 65804

e – mail : [email protected]

Page 41: PRESENTATION  OVERVIEW

Recommend Readings

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Public Health Service Substance Abuse and Mental Health Services

Administration Center for Substance Abuse Treatment TREATMENT IMPROVEMENT PROTOCOL (TIP) SERIES Rockwall II, 5600 Fishers Lane Rockville, MD 20857

Page 42: PRESENTATION  OVERVIEW

References and Recommended Readings American Psychiatric Association (2000). The

Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, The American Psychiatric Association.

Cooper, J., F. Bloom, and R. Roth. The Biochemical Basis of Neuropharmacology, 8th ed. Oxford, U.K.: Oxford University Press, 2003.

Kandel, E.,J.Schwartz, and T. Jessell. The Foundations of Neural Science, 4th ed. Boston, MA: McGraw Hill, 2000.

Page 43: PRESENTATION  OVERVIEW

Ray, O., Ksir, C. :Drugs Society, and Human Behavior,

7th ed., Mosby Publishing Co. (1996).

Squire, L. : Memory and Brain, Oxford, U.K.: Oxford University Press, (1987).

Whishaw. Il, and B. Kolb. Fundmentals of Human Neuropsychology, 5th ed. New York: Worth Books, (2003).


Recommended